Tehranian,N. , Sepehri,H. , Biramijamal,F. , Mehdipour,P. , Hossein-Nezhad,A. , Sarrafnejad,A. , Hajizadeh,E. and Delphi,L. (2020). The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines. Daneshvar Medicine, 19(4), 65-78.

Tehranian,N. , , Sepehri,H. , , Biramijamal,F. , , Mehdipour,P. , , Hossein-Nezhad,A. , , Sarrafnejad,A. , , Hajizadeh,E. , and Delphi,L. . "The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines", Daneshvar Medicine, 19, 4, 2020, 65-78.

Tehranian N., Sepehri H., Biramijamal F., Mehdipour P., Hossein-Nezhad A., Sarrafnejad A., Hajizadeh E., Delphi L. (2020). 'The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines', Daneshvar Medicine, 19(4), pp. 65-78.

N. Tehranian, H. Sepehri, F. Biramijamal, P. Mehdipour, A. Hossein-Nezhad, A. Sarrafnejad, E. Hajizadeh and L. Delphi, "The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines," Daneshvar Medicine, 19 4 (2020): 65-78,

Tehranian N., Sepehri H., Biramijamal F., Mehdipour P., Hossein-Nezhad A., Sarrafnejad A., Hajizadeh E., Delphi L. The effect of modified citrus pectin (MCP) on viability, morphology, and cell cycle arrest of DU-145 and LNCaP prostate cancer cell lines. Daneshvar Med, 2020; 19(4): 65-78.